http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7097970-B2

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_089a49bf15479864c2ffa34dc1bbffe7
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-5044
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-5008
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-502
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q1-703
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-50
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-68
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-09
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-70
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N5-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-15
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-02
filingDate 2001-06-04-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 2006-08-29-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c94a8756ba537083f1c50c1c4b4090a4
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_674f4a7059da294e86ea8bea1738486d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_261b8e103ccf2286ef2f5d24e556e384
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a7932b65ae05d403b211845ea4934f17
publicationDate 2006-08-29-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber US-7097970-B2
titleOfInvention Methods of evaluating viral entry inhibitors using patient derived envelope protein constructs
abstract The invention provides a method for identifying whether a compound inhibits entry of a virus into a cell which comprises: (a) obtaining nucleic acid encoding a viral envelope protein from a patient infected by the virus; (b) co-transfecting into a first cell (i) the nucleic acid of step (a), and (ii) a viral expression vector which lacks a nucleic acid encoding an envelope protein, and which comprises an indicator nucleic acid which produces a detectable signal, such that the first cell produces viral particles comprising the envelope protein encoded by the nucleic acid obtained from the patient; (c) contacting the viral particles produced in step (b) with a second cell in the presence of the compound, wherein the second cell expresses a cell surface receptor to which the virus binds; (d) measuring the amount of signal produced by the second cell in order to determine the infectivity of the viral particles; and (e) comparing the amount of signal measured in step (d) with the amount of signal produced in the absence of the compound, wherein a reduced amount of signal measured in the presence of the compound indicates that the compound inhibits entry of the virus into the second cell.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2008227084-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-2025762-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9506121-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2004121318-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2010323340-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2006003319-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8119339-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2011229906-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7718356-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2009117548-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11499200-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10550441-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2007084568-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9175355-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11459624-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2006194227-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2010323341-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9841425-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2009035749-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10385411-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9581595-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7709191-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2010330549-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8603736-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7294458-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2011033836-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2009047662-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2014272930-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2019025305-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2008020370-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2010047765-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8114585-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2005287170-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2009220939-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10358683-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7943297-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9493847-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2008096209-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2011086048-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7344830-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10161931-B2
priorityDate 2001-06-04-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-0181608-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6406911-B1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-9727319-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6103462-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-03070985-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5939320-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6242187-B1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5837464-A
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129329937
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID78654
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID8097
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129722732
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226423478
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226420667
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID57199466
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226398328
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID64139
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID65016
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226402238
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226398153
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129083291
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129815097
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID441243
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128681033
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226442357
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID392622
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID127474766
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3290
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226420570

Total number of triples: 94.